125 related articles for article (PubMed ID: 12612475)
1. Differentiation of soft tissue haemangioma by 201Tl scintigraphy.
Higuchi T; Taki J; Nakajima K; Kinuya S; Nonomura A; Tsuchiya H; Bunko H; Namura M; Tonami N
Nucl Med Commun; 2003 Mar; 24(3):327-30. PubMed ID: 12612475
[TBL] [Abstract][Full Text] [Related]
2. Intense 201 Tl uptake in giant-cell tumour of bone.
Higuchi T; Taki J; Sumiya H; Kinuya S; Bunko H; Nonomura A; Tsuchiya H; Tonami N
Nucl Med Commun; 2002 Jun; 23(6):595-9. PubMed ID: 12029217
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
[TBL] [Abstract][Full Text] [Related]
4. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
[TBL] [Abstract][Full Text] [Related]
5. Thallium-201 scintigraphy--a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?
Choong PF; Nizam I; Ngan SY; Schlict S; Powell G; Slavin J; Smith P; Toner G; Hicks R
Eur J Surg Oncol; 2003 Dec; 29(10):908-15. PubMed ID: 14624787
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors.
Nishiyama Y; Yamamoto Y; Yokoe K; Kawaguchi Y; Toyama Y; Satoh K; Ohkawa M
Ann Nucl Med; 2004 May; 18(3):235-41. PubMed ID: 15233285
[TBL] [Abstract][Full Text] [Related]
7. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
[TBL] [Abstract][Full Text] [Related]
8. Thallium-201 scintigraphy in pediatric soft-tissue tumors.
Howman-Giles R; Uren RF; Shaw PJ
J Nucl Med; 1995 Aug; 36(8):1372-6. PubMed ID: 7629580
[TBL] [Abstract][Full Text] [Related]
9. Thallium-201 scintigraphy is an effective diagnostic modality to distinguish malignant from benign soft-tissue tumors.
Kawakami N; Kunisada T; Sato S; Morimoto Y; Tanaka M; Sasaki T; Sugihara S; Yanai H; Kanazawa S; Ozaki T
Clin Nucl Med; 2011 Nov; 36(11):982-6. PubMed ID: 21975384
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of bone and soft tissue lesion using 99mTc-MIBI: comparison with 201Tl and the relation to chemotherapeutic effect].
Sumiya H; Taki J; Tonami N; Asada N; Tsuchiya H; Tomita K
Kaku Igaku; 1997 Feb; 34(2):105-11. PubMed ID: 9095573
[TBL] [Abstract][Full Text] [Related]
11. [Quantitative assessment of 201Tl-SPECT in tumors of bone and soft tissue].
Matsui R; Komori T; Nakata Y; Doi K; Tabuchi K; Saika Y; Utsunomiya K; Adachi I; Shimizu T; Sueyoshi K; Narabayashi I; Morishita S
Kaku Igaku; 1999 Apr; 36(3):219-28. PubMed ID: 10358956
[TBL] [Abstract][Full Text] [Related]
12. Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma.
Maini CL; Tofani A; Sciuto R; Carpano S; Crecco M; Manni C; Lopez M
Clin Nucl Med; 1994 Jul; 19(7):607-10. PubMed ID: 7924102
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors.
Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Ohkawa M; Tanabe M
Clin Nucl Med; 2000 Mar; 25(3):200-5. PubMed ID: 10698418
[TBL] [Abstract][Full Text] [Related]
14. [Clinical usefulness of thallium-201 chloride in the diagnosis of tumor (II)--An evaluation in bone, soft tissue and mediastinal tumors].
Tonami N; Itoh K; Yui N; Terui S; Torizuka K
Kaku Igaku; 1994 Jan; 31(1):63-74. PubMed ID: 8309112
[TBL] [Abstract][Full Text] [Related]
15. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
Taki J; Higuchi T; Sumiya H; Tsuchiya H; Minato H; Tomita K; Tonami N
J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphy for interpretation of malignant tumours of the head and neck: comparison of technetium-99m-hexakis-2-methoxyisobutylisonitrile (Tc-MIBI) and thallium-201-chloride (Tl-201).
Sato T; Kawabata Y; Kobayashi Y; Suenaga S; Indo H; Kawano K; Iwashita Y; Morita Y; Majima HJ
Dentomaxillofac Radiol; 2005 Sep; 34(5):268-73. PubMed ID: 16120875
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
[TBL] [Abstract][Full Text] [Related]
18. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
19. Thallium-201 Uptake of Giant Cell Tumor: One Step Toward the Differential Diagnosis to Atypically Presenting Osteosarcoma.
Keller S; Inai R; Sato S; Tada A; Adam G; Yamamura J; Kanazawa S
AJR Am J Roentgenol; 2017 Jan; 208(1):171-179. PubMed ID: 27726429
[TBL] [Abstract][Full Text] [Related]
20. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.
Sumiya H; Taki J; Tsuchiya H; Nonomura A; Miyauchi T; Tonami N
J Nucl Med; 1998 Sep; 39(9):1600-4. PubMed ID: 9744351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
